RARE-39. COMBINATION OF TUMOR TREATING FIELDS (TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

BACKGROUND: TTFields combined with TMZ chemotherapy demonstrated significantly improved PFS, OS and long-term survival in newly diagnosed glioblastoma (ndGBM) patients in the EF-14 trial; independent of MGMT-promoter methylation-status, age, grade of resection, and performance status. Recently, impr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Lazaridis, Lazaros, Schäfer, Niklas, Schmidt, Teresa, Weller, Johannes, Tzaridis, Theophilos-Dimitrios, Scheffler, Björn, Pierscianek, Daniela, Kleinschnitz, Christoph, Stuschke, Martin, Sure, Ulrich, Herrlinger, Ulrich, Kebir, Sied, Glas, Martin
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Rare Tumors
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847063/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.962
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares